Alpha memo: metformin resistance cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Rename the memo to remove the term 'resistance' from the title to avoid implying a resistance mechanism; instead, use phrasing that reflects cross-context heterogeneity (e.g., 'metformin exercise cross-context heterogeneity signal').
2. Clarify in the abstract and 'Why this is surprising' section that the memo is explicitly not claiming metformin causes resistance to exercise effects, but rather that the metformin+exercise combination may have heterogeneous outcomes across contexts, to preempt misinterpretation.

Minor issues

• Title uses 'metformin resistance' which may imply a resistance mechanism rather than cross-context heterogeneity; consider renaming to 'metformin exercise cross-context heterogeneity signal' or similar to better reflect the memo's focus on context-dependent effects across species and modalities.

Reviewer note

The memo presents a bounded, source-grounded research signal comparing a rodent fructose-induced insulin resistance model (Receipt 1) and a human type 2 diabetes trial (Receipt 2) to explore heterogeneous metformin+exercise effects across contexts. The claim is proportionate to the cited evidence, and the synthesis is coherent and well-integrated. Limitations and gaps are specific and actionable. The only material issue is the title's use of 'metformin resistance,' which risks implying a resistance mechanism rather than cross-context heterogeneity; a rename would resolve this without altering the core argument.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak

Prompt: reviewer-v11-research-synthesis